Paul Andrew Moore

CIK 1938192 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 6, 2023 · Latest: Jan. 6, 2023

On this page

Insider at

Insider transactions

0 buys (P) 3 sells (S) Net: $-721,486 + 21 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

21 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 12, 2026 ZYME S 9,560 $22.67 $216,725 48,497 Direct -16.47% Disposed 17.6% (price as of 2026-08-20)
Jan. 5, 2026 ZYME S 10,821 $25.10 $271,607 40,391 Direct -21.13% Disposed 6.3% (price as of 2026-08-20)
Jan. 5, 2026 ZYME S 9,289 $25.10 $233,154 31,212 Direct -22.94% Disposed 6.3% (price as of 2026-08-20)
Jan. 6, 2025 ZYME S 11,408 $14.92 $170,207 23,333 Direct -32.84% Disposed 78.8% (price as of 2026-08-20)
Jan. 6, 2025 ZYME S 9,792 $14.92 $146,097 14,741 Direct -39.91% Disposed 78.8% (price as of 2026-08-20)
Jan. 8, 2024 ZYME S 2,339 $11.22 $26,244 7,367 Direct -24.10% Disposed 137.7% (price as of 2026-08-20)
Jan. 5, 2024 ZYME S 7,460 $10.65 $79,449 9,706 Direct -43.46% Disposed 150.4% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Jan. 12, 2026 ZYME Performance Stock Unit Common Stock (66,000) — — 66,000 Acquired
Jan. 12, 2026 ZYME Restricted Stock Unit Common Stock (47,000) — — 47,000 Acquired
Jan. 12, 2026 ZYME Stock Option (Right to Buy) Common Stock (70,000) $23.16 Jan. 11, 2036 70,000 Acquired
Jan. 12, 2026 ZYME Restricted Stock Unit Common Stock (17,666) — — 17,666 Disposed
Jan. 5, 2026 ZYME Restricted Stock Unit Common Stock (20,000) — — 20,000 Disposed
Jan. 5, 2026 ZYME Restricted Stock Unit Common Stock (17,168) — — 17,168 Disposed
Jan. 10, 2025 ZYME Restricted Stock Unit Common Stock (53,000) — — 53,000 Acquired
Jan. 10, 2025 ZYME Stock Option (Right to Buy) Common Stock (79,000) $13.22 Jan. 9, 2035 79,000 Acquired
Jan. 6, 2025 ZYME Restricted Stock Unit Common Stock (20,000) — — 20,000 Disposed
Jan. 6, 2025 ZYME Restricted Stock Unit Common Stock (17,166) — — 17,166 Disposed
Jan. 5, 2024 ZYME Restricted Stock Unit Common Stock (60,000) — — 60,000 Acquired
Jan. 5, 2024 ZYME Stock Option (Right to Buy) Common Stock (90,000) $10.56 Jan. 4, 2034 90,000 Acquired
Jan. 5, 2024 ZYME Restricted Stock Unit Common Stock (17,166) — — 17,166 Disposed
Jan. 5, 2023 ZYME Restricted Stock Unit Common Stock (51,500) — — 51,500 Acquired
Jan. 5, 2023 ZYME Stock Option (Right to Buy) Common Stock (77,500) $8.00 Jan. 4, 2033 77,500 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ZYME

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2023 $465,784 — — — $182,120 — $224,762 $1,682,237

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.